These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines. Ozpolat B; Rao XM; Powell MF; Lachman LB AIDS Res Hum Retroviruses; 1998 Mar; 14(5):409-17. PubMed ID: 9546800 [TBL] [Abstract][Full Text] [Related]
10. Clinical hypothesis: Application of AIDS vaccines together with thyroid hormones to increase their immunogenic effect. Halabe Bucay A Vaccine; 2007 Aug; 25(33):6292-3. PubMed ID: 17570565 [TBL] [Abstract][Full Text] [Related]
11. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Bower JF; Green TD; Ross TM Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849 [TBL] [Abstract][Full Text] [Related]
12. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. Wang X; Uto T; Akagi T; Akashi M; Baba M J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261 [TBL] [Abstract][Full Text] [Related]
13. A need for effective adjuvants. Bunce CJ; Morse MA Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464 [No Abstract] [Full Text] [Related]
14. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides. Jiang JQ; Patrick A; Moss RB; Rosenthal KL J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832 [TBL] [Abstract][Full Text] [Related]
15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
20. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine. Wang X; Uto T; Akagi T; Akashi M; Baba M J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]